Banzel is available in different formulations, including oral tablets and oral suspension (liquid), and is taken by mouth. The dosage and frequency of administration depend on the patient’s age, weight, and the severity of the condition.
For children, the dose typically starts low and is gradually increased to minimize the risk of side effects.
For adults, the initial dose can be adjusted based on the clinical response and tolerability.
The dosage is typically twice a day with or without food.
Tablet Preparations
If it is the tablet preparation then it should be swallowed with water. But it should not be bitten or crushed.
Though it remains obscure how Banzel operates in humans, it is supposed that mainly Banzel modulates sodium channels within the brain. This set of channels controls electrical activity from the nerve cells.
Delayed Sodium Channel Opening: By delaying the opening of the sodium channels within the neuron, Banzel allows for a decrease in excitability of the neurons; thereby, there would not be rapid electrical discharging leading to seizure.
Reduces the probability of seizure generation and propagation by stabilizing electrical activity in the brain and, therefore, reduces seizures associated with conditions like Lennox-Gastaut syndrome.
Banzel specifically affects sodium channels most optimally in the treatment of seizures seen in Lennox-Gastaut syndrome; that is, where most of the seizure types occur that are difficult to manage.
Any drug can cause side effects, but not everyone who takes Banzel will experience them. Common side effects of Banzel include:
Drowsiness and Fatigue: These are the most common side effects and may reduce over time as the body gets accustomed to the medication.
Headache: Headaches are experienced by some patients when using Banzel.
Nausea and Vomiting: Nausea, vomiting, or stomach discomfort may be due to digestive issues.
Dizziness: Dizziness or lightheadedness may be experienced, especially when getting up too fast.
Loss of Appetite: Some individuals may feel a reduced appetite while using Banzel.
Less common but more significant adverse effects include:
Behavioural Changes: In isolated reports, Banzel has been identified as causing mood changes, among others aggression, agitation, and depression.
Serious Allergic Reaction: Although rare, this may be an allergic reaction to the drug leading to swelling of the face, lips, or throat requiring immediate medical attention.
Suicidal Thoughts: Like most other antiepileptic drugs, Banzel has a Black Box Warning for increased risks of suicidal thoughts or behaviors.
Suicidal Thoughts or Behavior: Similar to other antiepileptic drugs, Banzel is associated with increased suicidal thoughts or behavior. Patients on Banzel should be regularly monitored for mood changes, depression, or suicidal thoughts.
Drug Interactions: Banzel may interact with other drugs, especially enzyme-inducing or -inhibiting agents. Patients should inform their physicians about all concomitant medications including over-the-counter medications.
Kidney and Liver Function: The concomitant use of Banzel should be done with caution in patients with liver and/or kidney disease, since they may have impaired metabolism.
Pregnancy and Breastfeeding: There is no well-established use of Banzel in pregnancy. If the potential benefit to the mother outweighs the risk to the fetus, Banzel may be used during pregnancy. Rufinamide is excreted in breast milk; therefore, caution is advised when breastfeeding.
Starting Dose: The standard starting dose of Banzel is 10 mg/kg/day, administered twice daily. The dosage should be titrated upward according to clinical response and tolerability.
Maintenance Dose: The dose is commonly escalated to a maintenance dose of 40 mg/kg/day in children, and for adults, the adjustment is made based on the patient’s body weight, age, and response to the drug.
Tapering: The dose of Banzel should be tapered up or down as appropriate to avoid side effects; the medication should not be withdrawn abruptly.
Banzel can only be obtained by prescription from a healthcare provider. Because dosing must be individualized, the dose will be determined by a healthcare provider based on the patient’s condition, weight, and medical history. Patients will need to follow up regularly to assess the effectiveness of the treatment and to make adjustments if necessary.